Ryanodine receptor and immune-related molecules in diabetic cardiomyopathy
Cheng-Ju Tian1, Jing-Hua Zhang2, Jinfeng Liu3
1College of Rehabilitation and Sports Medicine, Jinzhou Medical University, Jinzhou, China.
Insights
High blood sugar (hyperglycaemia) damages the heart, causing diabetic cardiomyopathy. This review explores how ryanodine receptors (RyRs) and immune signals interact to cause heart dysfunction and potential therapies.
Area of Science:
- Cardiovascular Biology
- Metabolic Disease Research
- Molecular Cardiology
Background:
- Hyperglycaemia is a primary driver of diabetic cardiomyopathy.
- It elevates reactive species (RCS, ROS, RNS), disrupts calcium balance, and promotes inflammation.
- Ryanodine receptor 2 (RyR2) is crucial for cardiac excitation-contraction coupling.
Purpose of the Study:
- To review new findings on cellular communication in diabetic cardiomyopathy.
- To elucidate the mechanistic link between RyRs and immune molecules in diabetes.
- To discuss therapeutic strategies targeting RyRs and immune pathways.
Main Methods:
- Literature review focusing on recent advancements.
- Analysis of post-translational modifications of RyRs.
- Examination of immune signaling pathways (e.g., IL-1) in cardiac disease.
Main Results:
- Post-translational modifications of RyRs by reactive species impair gating and calcium sensitivity.
- Cardiac inflammation, involving lymphocytes and IL-1, contributes to diabetic cardiomyopathy.
- Complex intercellular communication networks among cardiomyocytes, fibroblasts, and immune cells are implicated.
Conclusions:
- Dysregulation of RyRs and immune molecules are key in diabetic cardiomyopathy pathogenesis.
- Understanding these interactions offers novel therapeutic targets for diabetic heart complications.
Abstract:
Hyperglycaemia is a major aetiological factor in the development of diabetic cardiomyopathy. Excessive hyperglycaemia increases the levels of reactive carbonyl species (RCS), reactive oxygen species (ROS) and reactive nitrogen species (RNS) in the heart and causes derangements in calcium homeostasis, inflammation and immune-system disorders. Ryanodine receptor 2 (RyR2) plays a key role in excitation-contraction coupling during heart contractions, including rhythmic contraction and relaxation of the heart. Cardiac inflammation has been indicated in part though interleukin 1 (IL-1) signals, supporting a role for B and T lymphocytes in diabetic cardiomyopathy. Some of the post-translational modifications of the ryanodine receptor (RyR) by RCS, ROS and RNS stress are known to affect its gating and Ca2+ sensitivity, which contributes to RyR dysregulation in diabetic cardiomyopathy. RyRs and immune-related molecules are important signalling species in many physiological and pathophysiological processes in various heart and cardiovascular diseases. However, little is known regarding the mechanistic relationship between RyRs and immune-related molecules in diabetes, as well as the mechanisms mediating complex communication among cardiomyocytes, fibroblasts and immune cells. This review highlights new findings on the complex cellular communications in the pathogenesis and progression of diabetic cardiomyopathy. We discuss potential therapeutic applications targeting RyRs and immune-related molecules in diabetic complications.
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Myocarditis I: Introduction
Coronary Artery Disease I: Introduction
Insulin: The Receptor and Signaling Pathways
Cardiomyopathy II: Dilated Cardiomyopathy


